AddLife Aktsia

AddLife EBITDA

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest AddLife (ALIF B.ST) seisuga 10. aug 2026 on 993,00 M SEK. Eelmisel aastal oli EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) 1,52 B SEK — muutus −34,67% (madalam).

EBITDA

993,00 MSEK

YoY

−34,67%

Viimati uuendatud:

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest AddLife on 2026 993,00 M SEK. EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest AddLife oli 2025 1,52 B SEK. See väheneb −34,67% madalam võrreldes eelmise aastaga.
Access this data via the Eulerpool API

AddLife Aktsiate analüüs

Mida AddLife teeb? AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services. AddLife on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused AddLife aktsia kohta

AddLife EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) on 2026. aastal 993,00 M SEK.

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest AddLife muutus 1,52 B SEK-st 993,00 M SEK-ks, mis vastab −34,67% muutusele. Väärtus on madalam kui eelmisel aastal.

Eulpoolist leiate EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) AddLife täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

EBITDA mõõdab operatiivset sooritust enne finantsstruktuuri, maksustamiskeskkonna ja mitterahalist amortisatsioonimaksude mõju.

EBITDA = EBIT + amortisatsioon ja amortisatsioon

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) SEK on investorite jaoks määrav tegur. Selle näitaja muutused võivad signaliseerida põhialuste paranemist või halvenemist, mõjutades otseselt aktsia hinda. Eulpoolis saate EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) AddLife ajaloolist arengut ja reaalajas andmeid jälgida.

Access this data via the Eulerpool API

Kasumi- ja kahjumiaruanne — AddLife

Kõik finantsnäitajad — AddLife